Content about New Jersey

December 20, 2010

The president of Par Pharmaceutical's subsidiary announced his resignation on Monday.

WOODCLIFF LAKE, N.J. — The president of Par Pharmaceutical's subsidiary announced his resignation on Monday.

John MacPhee, who served as president of Strativa and Par EVP, will leave the company, effective Jan. 31, to pursue other interests.

Patrick LePore, Par's president, chairman and CEO, will assume day-to-day oversight of Strativa on an interim basis.

December 17, 2010

The Food and Drug Administration has approved a new oral contraceptive developed by Bayer.

WAYNE, N.J. — The Food and Drug Administration has approved a new oral contraceptive developed by Bayer.

Safyral is a combination of Yasmin, also developed by Bayer, with 451 mcg levomefolate calcium, which is a B vitamin known as a folate. It is the second oral contraceptive from Bayer that features folate.

December 17, 2010

In a major alliance to foster preventive health in the United States, Walgreens has partnered with the Department of Health and Human Services to provide free flu vaccinations to as many as 350,000 low-income and uninsured Americans.

DEERFIELD, Ill. — In a major alliance to foster preventive health in the United States, Walgreens has partnered with the Department of Health and Human Services to provide free flu vaccinations to as many as 350,000 low-income and uninsured Americans.

Walgreens will provide more than $10 million worth of vouchers for free flu shots, which HHS will help distribute.

December 16, 2010

Americans won’t take off work for something as innocuous as a cold, a new survey released Wednesday found, a fact that underscores the need for ready access to over-the-counter cough-cold medicines and better hand-washing/sanitizing practices in the workplace.

PARSIPPANY, N.J. — Americans won’t take off work for something as innocuous as a cold, a new survey released Wednesday found, a fact that underscores the need for ready access to over-the-counter cough-cold medicines and better hand-washing/sanitizing practices in the workplace.

The survey, sponsored by Cadbury Adams’ Halls cough drop brand, found that 44% of Americans would consider going to work with a fever, and 32% said they would show up to work no matter how sick they get this season.

December 16, 2010

A subsidiary of Watson Pharmaceuticals has entered a licensing agreement with a subsidiary of Hungarian drug maker Richter to develop and market a drug for uterine fibroids, the two companies said Thursday.

MORRISTOWN, N.J. — A subsidiary of Watson Pharmaceuticals has entered a licensing agreement with a subsidiary of Hungarian drug maker Richter to develop and market a drug for uterine fibroids, the two companies said Thursday.

Watson Labs and PregLem said European studies had shown Esmya (ulipristal acetate) to be a safe and effective treatment for the disease, a benign tumor condition that affects between one-fifth and one-fourth of women of reproductive age worldwide. Watson expected to start phase-3 studies of the drug in the United States in 2011.

December 15, 2010

Johnson & Johnson on Wednesday announced that Alex Gorsky, currently worldwide chairman of medical devices and diagnostics, and Sheri McCoy, currently worldwide chairman of pharmaceuticals, have been appointed vice chairmen of the executive committee, joining William Weldon, J&J chairman and CEO, in an expanded Office of the Chairman.

NEW BRUNSWICK, N.J. — Johnson & Johnson on Wednesday announced that Alex Gorsky, currently worldwide chairman of medical devices and diagnostics, and Sheri McCoy, currently worldwide chairman of pharmaceuticals, have been appointed vice chairmen of the executive committee, joining William Weldon, J&J chairman and CEO, in an expanded Office of the Chairman.

Both appointments are effective Jan. 3.

December 15, 2010

Drug maker Watson Pharmaceuticals said it has filed a regulatory approval application for a generic painkiller, challenging the patent that covers the branded version.

MORRISTOWN, N.J. — Drug maker Watson Pharmaceuticals said it has filed a regulatory approval application for a generic painkiller, challenging the patent that covers the branded version.

Watson announced Tuesday that it had filed an application with the Food and Drug Administration seeking approval for hydromorphone hydrochloride extended-release tablets in the 8-mg, 12-mg and 16-mg strengths. The drug is a generic version of Mallinckrodt’s Exalgo.

December 14, 2010

Bankrupt grocer A&P has announced that the U.S. Bankruptcy Court for the Southern District of New York has approved the $800 million debtor-in-possession financing provided by JPMorgan Chase. Of the total DIP facility, a $350 million term loan immediately has been made available.

MONTVALE, N.J. — Bankrupt grocer A&P has announced that the U.S. Bankruptcy Court for the Southern District of New York has approved the $800 million debtor-in-possession financing provided by JPMorgan Chase. Of the total DIP facility, a $350 million term loan immediately has been made available.

As previously reported, A&P filed for bankruptcy on Sunday and will keep its 395 stores open and operational during the proceedings.

In addition, the court granted A&P's motion to approve its request for "first day orders," including:

December 14, 2010

The Food and Drug Administration has approved a revised dosage for a drug combination, which includes a Johnson & Johnson drug, in HIV patients who have received treatment but whose virus has not become immune to the J&J drug.

TITUSVILLE, N.J. — The Food and Drug Administration has approved a revised dosage for a drug combination, which includes a Johnson & Johnson drug, in HIV patients who have received treatment but whose virus has not become immune to the J&J drug.

December 14, 2010

The Food and Drug Administration has accepted a regulatory approval application for a pain drug made by Pacira Pharmaceuticals, Pacira said Tuesday.

PARSIPPANY, N.J. — The Food and Drug Administration has accepted a regulatory approval application for a pain drug made by Pacira Pharmaceuticals, Pacira said Tuesday.

The drug maker submitted its application for the long-acting painkiller Exparel (bupivacaine) in September.

The drug is a topical medication for managing pain following surgery. The FDA expects to finish reviewing the application in July 2011.

December 13, 2010

Battling hefty debt and intense competition, grocer A&P filed for bankruptcy on Sunday and has secured $800 million in debtor-in-possession financing to keep the 395-store chain open and operational during the proceedings.

MONTVALE, N.J. — Battling hefty debt and intense competition, grocer A&P filed for bankruptcy on Sunday and has secured $800 million in debtor-in-possession financing to keep the 395-store chain open and operational during the proceedings.

December 10, 2010

Mizco recently inked a licensing agreement with Marc Ecko Enterprises, bringing the first-ever line of Ecko-inspired electronic accessory and mobile technology products to design-conscious technology enthusiasts.

AVENEL, N.J. — Mizco recently inked a licensing agreement with Marc Ecko Enterprises, bringing the first-ever line of Ecko-inspired electronic accessory and mobile technology products to design-conscious technology enthusiasts.

The Ecko line of Mizco products includes headphones; iPhone, iPad and MP3 cases; and camera accessories that are available for a suggested retail price ranging from $19.99 to $99.

December 9, 2010

Amneal Pharmaceuticals has named a drug industry attorney as SVP and general counsel, the generic drug maker said Thursday.

BRIDGEWATER, N.J. — Amneal Pharmaceuticals has named a drug industry attorney as SVP and general counsel, the generic drug maker said Thursday.

Amneal announced the appointment of Robert Loewenstein, who previously served as head of law firm Budd Larner, P.C.’s corporate generic pharmaceuticals practice.

December 8, 2010

Johnson & Johnson made its courtship with Dutch biotech company Crucell official by acquiring all of the company for $2.3 billion, the two companies said Wednesday.

NEW BRUNSWICK, N.J. — Johnson & Johnson made its courtship with Dutch biotech company Crucell official by acquiring all of the company for $2.3 billion, the two companies said Wednesday.

In a deal that won the full support of Crucell’s management, J&J will pay $32.74 per share for the remainder of Crucell that it doesn’t already own; J&J indirectly controls around 18% of Crucell’s stock through a Dutch affiliate, while Delta Lloyd Asset Management, Robeco and the Van Herk Group control around 15.5%, according to published reports.

December 8, 2010

New Leaf's line of lemonades was recognized at the BevNet Live Winter 10 forum.

OLD TAPPAN, N.J. — New Leaf's line of lemonades was recognized at the BevNet Live Winter 10 forum.

New Leaf took home the best of 2010 noncarbonated beverage award for its four lemonades, which are made with 6% to 10% of real fruit juice, the company said.

BevNet Live 10 is a premier beverage industry event that was held in Santa Monica, Calif., this week.

Last month, New Leaf announced it tapped New York Giants football wide receiver Steve Smith as its first celebrity spokesman.

December 8, 2010

Pfizer Consumer Healthcare on Tuesday launched a new consumer promotion campaign featuring television actress Angie Harmon in support of its Children’s Advil brand.

MADISON, N.J. — Pfizer Consumer Healthcare on Tuesday launched a new consumer promotion campaign featuring television actress Angie Harmon in support of its Children’s Advil brand.

December 7, 2010

The Food and Drug Administration has accepted for review a supplemental approval application for an arthritis drug made by Bristol-Myers Squibb, the drug maker said Monday.

PRINCETON, N.J. — The Food and Drug Administration has accepted for review a supplemental approval application for an arthritis drug made by Bristol-Myers Squibb, the drug maker said Monday.

Bristol is seeking approval for Orencia (abatacept) injected into the skin as a treatment for adults with moderate to severe rheumatoid arthritis. The drug already is approved for intravenous injection.

December 7, 2010


DUBLIN, Ohio — Say goodbye to Kinray, the service-obsessed regional drug wholesaler. But say hello to a more muscular and diversified Cardinal Health.


The wholesale and health services giant announced Nov. 18 it will buy Kinray for $1.3 billion. The buyout, set for completion in early 2011, will be a boon to Cardinal, boosting its customer base to more than 7,000 independent drug stores, extending its reach in the Northeast and adding scale versus its wholesale rivals, McKesson and AmerisourceBergen.


December 7, 2010

PARSIPPANY, N.J. — The Food and Drug Administration is exploring the benefits associated with the long-term use of nicotine-replacement therapy products, a factor expected to both extend the amount of time a person avails themselves of the smoking-cessation therapy, as well as increase the success rates for quit attempts. 


December 7, 2010

Looking to bolster sales and better serve its customers, Walmart has stepped up its engagement with suppliers to review its assortment and bring in more new and innovative products — and the beauty department is no exception.


December 7, 2010

U.S. generic drug maker Watson Pharmaceuticals and Indian drug maker Natco Pharma will work together to develop and commercialize a generic drug used for bone marrow disorders, the two companies said Tuesday.

MORRISTOWN, N.J. — U.S. generic drug maker Watson Pharmaceuticals and Indian drug maker Natco Pharma will work together to develop and commercialize a generic drug used for bone marrow disorders, the two companies said Tuesday.

The agreement concerns lenalidomide tablets in the 5-mg, 10-mg, 15-mg and 25-mg strengths. The drug is a generic version of Celgene’s Revlimid, used to treat the plasma cell cancer multiple myeloma and myelodysplastic syndrome. Myelodysplastic syndrome results from the bone marrow producing blood cells that are misshapen.

December 6, 2010

DSE Healthcare Solutions on Sunday evening announced the launch of Safari Towels, a new product extending from its Anti Monkey Butt Powder brand, to its Facebook fan base of almost 39,000.

EDISON, N.J. — DSE Healthcare Solutions on Sunday evening announced the launch of Safari Towels, a new product extending from its Anti Monkey Butt Powder brand, to its Facebook fan base of almost 39,000.

“Our new Safari Towels ... so hot off the presses they aren't even in stores yet!” the Anti Monkey Butt Powder status read. “Make a cool gift ... from cyclists to soldiers, [they're] great to have on hand for a ‘shower on the go.’ See them in our online store.”

December 6, 2010

An investigational drug made by Watson Pharmaceuticals and Columbia Labs reduced the risk of premature birth, according to results of late-stage clinical trial.

MORRISTOWN, N.J. — An investigational drug made by Watson Pharmaceuticals and Columbia Labs reduced the risk of premature birth, according to results of a late-stage clinical trial.

The two companies announced results Monday of a phase-3 trial of Prochieve (progesterone), a vaginal gel, saying that it produced a significant reduction in the number of preterm births. The trial was conducted under a collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health.

December 2, 2010

Pfizer Consumer Healthcare on Thursday introduced a new contest from the makers of Centrum multivitamins at LoveFeelingHealthy.com ...

MADISON, N.J. — Pfizer Consumer Healthcare on Thursday introduced a new contest from the makers of Centrum multivitamins at LoveFeelingHealthy.com. Participants there can nominate women who manage to stay energized this holiday season with a smile on their face.

Nominators can share how the special woman in their lives manages to be the ultimate host, party charmer, gift giver, cookie baker, etc. Participants are asked to submit 300 words that explain how that woman does it all.

December 2, 2010

Merck announced on Thursday it has inked a deal to acquire an insulin maker.

WHITEHOUSE STATION, N.J., and BEVERLY, Mass. (Dec. 2) Merck announced on Thursday it has inked a deal to acquire an insulin maker.